Standard Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-73,500
Closed -$1.1M 54
2015
Q2
$1.1M Buy
+73,500
New +$1.1M 0.06% 76